How We’re Mobilizing Our Resources to Help Find Solutions for COVID-19
Learn More
Share
Cancer
Surprising new research suggests that people younger than 50 are getting diagnosed with the disease at record rates. For National Colorectal Cancer Awareness month, find out how to protect yourself—no matter what your age.
A new report from the American Cancer Society sheds light on declining death rates from cancer—especially lung cancer. We asked an expert on the disease to break down the data, and share what's to come in better detecting and preventing it.
A groundbreaking trial for an HIV vaccine. New ways to help the body heal itself. Immunotherapy treatments for cancer. Behind medical advancements like these are the brilliant scientists who are relentlessly pushing their visions and research forward.
From a first-of-its-kind contact lens that darkens when exposed to bright light to the first donation of 500,000 doses of an Ebola vaccine, here are just some of the ways Johnson & Johnson helped change the trajectory of health for humanity this past year.
For Prostate Cancer Awareness Month, we sat down with Margaret Yu, M.D., Vice President, Disease Area Leader, Prostate Cancer, Janssen Research & Development, to learn more about the latest scientific strides being made in the battle against one of the most common cancers in men.
Siddhartha Mukherjee, M.D., made his name as an oncologist, researcher and Pulitzer Prize-winning writer. Now he's the scientific adviser of an immuno-oncology start-up that's tackling a rare form of leukemia. In an exclusive interview, he reveals his vision for the future of cancer treatments.
A team of scientists, including those from Janssen and the Lung Cancer Initiative at Johnson & Johnson, found that biomarkers related to the immune system may be able to aid doctors in identifying high-risk lung cancer patients—and treating them—at the earliest stage of the disease.
We retrace the 22-year journey it took to bring a potentially life-changing treatment for an aggressive form of the disease to patients who may benefit most.
Brad Heidrich’s diagnosis with a deadly cancer at age 13 changed the course of his life—and inspired the person he would become: a Janssen scientist dedicated to working on therapies for blood cancer. For Myeloma Action Month, we share his incredible story.
Some 20% of people diagnosed with the disease haven't touched a cigarette. For National Cancer Prevention Month, scientists who've dedicated their research to defeating lung cancer discuss why early detection is so key—and what you can do to protect yourself.
From breakthrough work to eradicate some of the world's deadliest diseases to advancements in cutting-edge health technology, see just some of the ways Johnson & Johnson is working to help change the trajectory of health for humanity.
The doctor overseeing the company's new Lung Cancer Initiative reveals why it's uniquely qualified to work on thwarting the disease—and why he's uniquely qualified to oversee its efforts.
We sat down with the winner of the 2018 Dr. Paul Janssen Award for Biomedical Research to learn how his tireless cancer research efforts have helped revolutionize the way we treat the disease—and save lives.
Johnson & Johnson and Chinese company Legend Biotech have teamed up to work on a new form of treatment for the incurable blood cancer. We interview Dr. Sen Zhuang about the unique collaboration—and the promise it holds.
Have you been putting off getting your prostate checked? National Cancer Prevention Month is the perfect time to tackle this important medical to-do. Just ask Ron Scolamiero, who was surprised by a prostate cancer diagnosis at 54. He shares his story of resilience.
